{"id":"W2760908566","doi":"10.1200/jco.2016.34.15_suppl.tps10587","title":"A phase I study of the EZH2 inhibitor tazemetostat in pediatric subjects with relapsed or refractory INI1-negative tumors or synovial sarcoma.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; SMARCB1; Synovial sarcoma; EZH2; Cancer research; SMARCA4; Epithelioid sarcoma; Internal medicine; Sarcoma; Chromatin remodeling; Oncology; Pathology; Chromatin; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001797343,0.0001606329,0.0007941894,0.00008731271,0.00003594175,0.000004909908,0.0003361763,0.0002771728,0.00003277092],"category_scores_gemma":[0.005478039,0.00006550257,0.0001908856,0.0002391704,0.0002039344,0.00001172321,0.0001108172,0.0004670268,0.000001379575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007638501,"about_ca_system_score_gemma":0.002858158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002585036,"about_ca_topic_score_gemma":0.0009034127,"domain_scores_codex":[0.9965601,0.0008495768,0.001796535,0.0002548314,0.0003275017,0.0002114861],"domain_scores_gemma":[0.9961457,0.001147465,0.001933439,0.0002889025,0.0003482775,0.0001362236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2781213,0.05763263,0.287343,0.0001869421,0.001252779,0.001702242,0.002524627,0.0002485467,0.07310127,0.00001079514,0.01065439,0.2872215],"study_design_scores_gemma":[0.2381485,0.575235,0.1379574,0.000785595,0.0009367985,0.0005679341,0.004325478,0.00008550967,0.02606141,0.0002242256,0.01476119,0.0009109542],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983557,0.0001247414,0.00006638213,0.0004262979,0.0005925408,0.0002796259,0.000008019858,0.000002598189,0.0001440492],"genre_scores_gemma":[0.9975815,0.0003660638,0.0004198018,0.000239492,0.001097201,0.000007472152,5.214e-7,0.00001957507,0.0002683193],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5176024,"threshold_uncertainty_score":0.655812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06141633266939515,"score_gpt":0.4145799057125616,"score_spread":0.3531635730431664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}